Literature DB >> 7848894

Is the senescent heart overloaded and already failing?

S Besse1, C Delcayre, B Chevalier, S Hardouin, C Heymes, F Bourgeois, J M Moalic, B Swynghedauw.   

Abstract

Heart failure mainly occurs during the last decades of life, and it is important to know if the senescent heart is not an already failing heart. During aging, both contraction and relaxation of papillary muscle are impaired. Such an impairment is compensated in vivo and the cardiac output remains normal. In spite of a loss in myocytes, the heart weight/body weight ratio is unchanged, but the myocytes are bigger. Arrhythmias are permanent and are accompanied by a loss of the normal heart rate variability. Changes in specific mRNAs include: a shift in myosin heavy chain (MHC) isogene expression leading to an increased beta MHC content; decreased densities of Ca2+ ATPase of the sarcoplasmic reticulum, beta 1-adrenergic receptor, and muscarinic receptors; and attenuation of the Na+/Ca2+ exchange activity. Most of these changes, but not all, resemble those observed during cardiac overload and are accompanied by an increased duration of both the action potential and the intracellular calcium transient. However, the senescent heart is still able to further modify its phenotype in response to mechanical overload. The senescent heart is a diseased heart, and the origin of the "disease" is multifactorial and includes the general process of senescence, hormonal changes, and the myocardial consequences of senescence of the vessels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7848894     DOI: 10.1007/bf00877412

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  47 in total

1.  Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy.

Authors:  G Olivetti; M Melissari; J M Capasso; P Anversa
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

2.  Alterations in beta adrenergic and muscarinic receptors in aged rat heart. Effects of chronic administration of propranolol and atropine.

Authors:  B Chevalier; P Mansier; E Teiger; F Callen-el Amrani; B Swynghedauw
Journal:  Mech Ageing Dev       Date:  1991-10       Impact factor: 5.432

Review 3.  Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles.

Authors:  B Swynghedauw
Journal:  Physiol Rev       Date:  1986-07       Impact factor: 37.312

4.  [Changes in the aging human heart. I. Heart weight in the aged].

Authors:  A J Linzbach; E Akuamoa-Boateng
Journal:  Klin Wochenschr       Date:  1973-02-15

5.  Do hypertension and aging have a similar effect on the myocardium?

Authors:  E G Lakatta
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

6.  Mechanical properties of myocardium from hypertrophied rat hearts. A comparison between hypertrophy induced by senescence and by aortic banding.

Authors:  F C Yin; H A Spurgeon; M L Weisfeldt; E G Lakatta
Journal:  Circ Res       Date:  1980-02       Impact factor: 17.367

7.  Effects of age on mechanical and electrical performance of rat myocardium.

Authors:  J M Capasso; A Malhotra; R M Remily; J Scheuer; E H Sonnenblick
Journal:  Am J Physiol       Date:  1983-07

8.  Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study.

Authors:  D Levy; K M Anderson; D D Savage; S A Balkus; W B Kannel; W P Castelli
Journal:  Am J Cardiol       Date:  1987-09-01       Impact factor: 2.778

9.  Cardiac adaptations to aortic constriction in adult and aged rats.

Authors:  M O Boluyt; J A Opiteck; K A Esser; T P White
Journal:  Am J Physiol       Date:  1989-08

10.  Contractile and biochemical correlates of beta-adrenergic stimulation of the aged heart.

Authors:  T Guarnieri; C R Filburn; G Zitnik; G S Roth; E G Lakatta
Journal:  Am J Physiol       Date:  1980-10
View more
  6 in total

1.  Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.

Authors:  Tura C Camilli; Mai Xu; Michael P O'Connell; Bonnie Chien; Brittany P Frank; Sarah Subaran; Fred E Indig; Patrice J Morin; Stephen M Hewitt; Ashani T Weeraratna
Journal:  Pigment Cell Melanoma Res       Date:  2010-12-01       Impact factor: 4.693

2.  Cardioprotection and ageing.

Authors:  Yon Hee Shim
Journal:  Korean J Anesthesiol       Date:  2010-03-30

Review 3.  Is physical activity able to modify oxidative damage in cardiovascular aging?

Authors:  Graziamaria Corbi; Valeria Conti; Giusy Russomanno; Giuseppe Rengo; Piergiusto Vitulli; Anna Linda Ciccarelli; Amelia Filippelli; Nicola Ferrara
Journal:  Oxid Med Cell Longev       Date:  2012-09-16       Impact factor: 6.543

Review 4.  Mitochondria and aging: A role for the mitochondrial transition pore?

Authors:  Mathieu Panel; Bijan Ghaleh; Didier Morin
Journal:  Aging Cell       Date:  2018-06-11       Impact factor: 9.304

Review 5.  Adrenergic signaling and oxidative stress: a role for sirtuins?

Authors:  Graziamaria Corbi; Valeria Conti; Giusy Russomanno; Giancarlo Longobardi; Giuseppe Furgi; Amelia Filippelli; Nicola Ferrara
Journal:  Front Physiol       Date:  2013-11-08       Impact factor: 4.566

6.  Deficiency of Senescence Marker Protein 30 Exacerbates Cardiac Injury after Ischemia/Reperfusion.

Authors:  Shinpei Kadowaki; Tetsuro Shishido; Toshiki Sasaki; Takayuki Sugai; Taro Narumi; Yuki Honda; Yoichiro Otaki; Daisuke Kinoshita; Tetsuya Takahashi; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Takuya Miyamoto; Tetsu Watanabe; Akihiko Ishigami; Yasuchika Takeishi; Isao Kubota
Journal:  Int J Mol Sci       Date:  2016-04-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.